Follow The Filings

MRKR Marker Therapeutics

Marker Therapeutics earnings company data as of 4:48 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —
FY2026 Q2 14 Aug EPS — -0.09 —
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 8.01,9.01
10-Q
10-Q
8-K 5.03,5.07,9.01
DEF 14A FORM DEF 14A
DEFA14A
8-K 2.02,9.01
10-K
8-K 5.08,9.01
SCHEDULE 13D/A —
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K 5.02,8.01,9.01
8-K 8.01,9.01
8-K 7.01,9.01
SCHEDULE 13D/A —
SCHEDULE 13D/A —
SCHEDULE 13D/A —
10-Q
8-K 4.01,9.01
424B7
8-K 1.01,8.01,9.01
8-K 5.07,9.01
8-K 8.01,9.01

Insider forms

Forms 3, 4 and 5 from EDGAR, 2 rows shown

Filed Form Detail Links
4 Period Nov 17, 2025 (3 forms)
4 Period Oct 31, 2025 (2 forms)

1 more insider forms

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.